Gene · 51514
Papers1,470
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,470
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| How Do Cognitive and Motor Dual-Tasks during Small-Sided Games Impact the Tactical Performance of Youth Soccer Players? | J Hum Kinet | 2025 | 40463312 | PubTator, text mining | PubMed |
| Denticleless homolog-mediated ubiquitin-proteasome degradation of forkhead box O1 contributes to development of carboplatin resistance in retinoblastoma. | Anticancer Drugs | 2025 | 40455648 | PubTator, text mining | PubMed |
| Rewired glycolysis by DTL accelerates oncometabolite L-lactate generation to promote breast cancer progression. | Front Oncol | 2025 | 40391156 | PubTator, text mining | PubMed |
| Intra-tumoural RAMP1+ B cells promote resistance to neoadjuvant anti-PD-1-based therapy in oesophageal squamous cell carcinoma. | Immunother Adv | 2025 | 40385640 | PubTator, text mining | PubMed |
| HiViT-IDS: An Efficient Network Intrusion Detection Method Based on Vision Transformer. | Sensors (Basel) | 2025 | 40292892 | PubTator, text mining | PubMed |
| Construction of ubiquitination-related risk model for predicting prognosis in lung adenocarcinoma. | Sci Rep | 2025 | 40189665 | PubTator, text mining | PubMed |
| HBx/DTL Positive Feedback Loop Promotes HBV-Related Hepatocellular Carcinoma Progression. | J Med Virol | 2025 | 40062428 | PubTator, text mining | PubMed |
| MiR-3202-DTL signaling axis impedes NSCLC malignancy via regulating the ubiquitination-proteasome degradation of p21. | Mol Cell Biochem | 2025 | 40038150 | PubTator, text mining | PubMed |
| Comparative analysis of chromatin accessibility in porcine oocytes from follicles of different sizes. | Res Vet Sci | 2025 | 39908890 | PubTator, text mining | PubMed |
| The impact of digital transformational leadership on digital intensity among primary healthcare entities: a moderated mediation model. | BMC Health Serv Res | 2025 | 39838353 | PubTator, text mining | PubMed |
| cDTL contributes to breast cancer progression through regulating redox homeostasis via affecting the function of system xc. | Biochem Biophys Res Commun | 2025 | 39706052 | PubTator, text mining | PubMed |
| Covalent Proximity Inducers. | Chem Rev | 2025 | 39692621 | PubTator, text mining | PubMed |
| Statistical modeling of single-cell epitranscriptomics enabled trajectory and regulatory inference of RNA methylation. | Cell Genom | 2025 | 39642887 | PubTator, text mining | PubMed |
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer. | Int J Gynecol Cancer | 2025 | 39375168 | PubTator, text mining | PubMed |
| LINCRNA01094 Promotes Renal Interstitial Fibrosis via the Mir-513b-5p/ MELK/Smad3 Axis. | Endocr Metab Immune Disord Drug Targets | 2025 | 39318012 | PubTator, text mining | PubMed |
| Computer-aided design of caffeic acid derivatives: free radical scavenging activity and reaction force. | J Mol Model | 2024 | 39729167 | PubTator, text mining | PubMed |
| Deciphering molecular landscape of breast cancer progression and insights from functional genomics and therapeutic explorations followed by in vitro validation. | Sci Rep | 2024 | 39567714 | PubTator, text mining | PubMed |
| Robustly learning the Hamiltonian dynamics of a superconducting quantum processor. | Nat Commun | 2024 | 39505860 | PubTator, text mining | PubMed |
| DTL promotes the growth and migration of melanoma cells through the ERK/E2F1/BUB1 axis. | Sci Rep | 2024 | 39487277 | PubTator, text mining | PubMed |
| Evaluation of Genes and Molecular Pathways Involved in Pathogenesis of Sickle Cell Anemia: A Bioinformatics Analysis and Future Perspective. | Iran J Public Health | 2024 | 39430157 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51514/papers?page=3